Ads
related to: metastatic colorectal cancer treatment- EGFR & RAS Mutations
Read More About The Link Between
EFGR And RAS Mutations In mCRC.
- Biomarker Testing
Explore Guidelines And Recommended
Testing Options For RAS Mutations.
- About KRAS G12C In mCRC
Learn More About The Prevalence Of
KRAS G12C In Patients With mCRC.
- RAS Mutations
See Information About RAS Mutation
In Metastatic Colorectal Cancer.
- EGFR & RAS Mutations
Search results
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 18 hours agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
Treating Patients With Cancer From Prison: A Complex Reality
Medscape· 1 day agoProf David Kerr discusses treatment considerations for prisoners with cancer.
Successful trial for new colorectal cancer treatment highlights promising immunotherapy drugs
Medical Xpress· 7 days agoAlthough immunotherapy has previously been shown to work on patients with specific mismatch repair deficient (dMMR) tumors, only a small percentage of colorectal ...
GenFleet receives China NMPA approval for Phase I/II solid tumour trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoIn April, the US Food and Drug Administration granted approval for GenFleet to commence a Phase III...
Huge breakthrough as scientists find 'game-changing' treatment for one cancer
Daily Express· 7 days agoA groundbreaking trial has discovered that two drugs typically used to strengthen immune systems can...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 7 days ago(NASDAQ:LIXT) has entered into a significant agreement with the Netherlands Cancer Institute (NKI)...
ChatGPT Accurately Defines Colonoscopy Screening Intervals
Medscape· 3 days agoDespite its accuracy, researchers warn that it may be too early to implement these recommendations in clinical practice.
Chemotherapy before surgery benefits some patients with pancreatic cancer, study finds
Medical Xpress· 16 hours agoThe findings, say the researchers, are encouraging for the 15 to 20% of pancreatic cancer patients whose tumors are operable. The single-arm (only one treatment< ...
Actuate Therapeutics (ACTU) to Raise $50 Million in IPO
ETF DAILY NEWS· 1 day agoActuate Therapeutics (ACTU) plans to raise $50 million in an initial public offering on the week of...
Early-Onset CRC Does Not Require More Intense Surveillance
Medscape· 4 days agoPatients with early-onset CRC did not have a greater risk for advanced polyps than their average-onset counterparts, calling into question their need for increased surveillance.
Ads
related to: metastatic colorectal cancer treatment